The Asia Pacific Transcatheter Aortic Valve Replacement Market should witness market growth of 8.5% CAGR during the forecast period (2022-2028).
A wire valve frame and bovine (cow) animal tissue leaflets comprise the transcatheter aortic valve replacement, intended to repair the damaged aortic valve. A catheter is inserted by the surgeon after making a little incision in an artery or blood vessel, most frequently in the groin. The catheter is squeezed and attached to the artificial valve, inserted into the damaged aortic valve through the blood vessel.
The surgeon will move the defective portions of the aortic valve leaflets out of the way and insert the new valve using cutting-edge imaging methods like X-rays. Once installed, the new valve will work and restore blood flow. The surgeon will next take out the catheter and sew up the wound. The patient will be moved to the recovery area and released a few days later. To stop more blood clots, doctors will give blood-thinning drugs.
Due to the aging population and rising incidence of illnesses, including heart disease and aortic stenosis, the transcatheter aortic valve replacement device market has grown rapidly over the past several years. Furthermore, one or more damaged heart valves may require repair or replacement surgery to address issues. Due to increased awareness of the advantages of aortic valve replacement and the availability of efficient treatments, more patients are pursuing this procedure.
It is anticipated that 34 countries will have over 20% of their population over 65 by 2030 due to the world's aging population. China's population is aging rapidly; as a result of rising life expectancy and falling birth rates, China's population of individuals over 60 is expected to increase to 28% by 2040. In particular, the creation of an integrated system that meets the social and health requirements of older people while ensuring that everyone has access to health care regardless of location is made possible by this enormous demographic transition. A rapidly aging population necessitates the development of age-friendly towns and cities where the elderly can flourish and make valuable contributions to society. To enhance access to integrated care, China has been researching novel strategies. These elements would support the growth of the regional market.
The China market dominated the Asia Pacific Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $614.3 million by 2028. The Japan market is estimated to grow a CAGR of 7.8% during (2022-2028). Additionally, The India market would experience a CAGR of 9.1% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
A wire valve frame and bovine (cow) animal tissue leaflets comprise the transcatheter aortic valve replacement, intended to repair the damaged aortic valve. A catheter is inserted by the surgeon after making a little incision in an artery or blood vessel, most frequently in the groin. The catheter is squeezed and attached to the artificial valve, inserted into the damaged aortic valve through the blood vessel.
The surgeon will move the defective portions of the aortic valve leaflets out of the way and insert the new valve using cutting-edge imaging methods like X-rays. Once installed, the new valve will work and restore blood flow. The surgeon will next take out the catheter and sew up the wound. The patient will be moved to the recovery area and released a few days later. To stop more blood clots, doctors will give blood-thinning drugs.
Due to the aging population and rising incidence of illnesses, including heart disease and aortic stenosis, the transcatheter aortic valve replacement device market has grown rapidly over the past several years. Furthermore, one or more damaged heart valves may require repair or replacement surgery to address issues. Due to increased awareness of the advantages of aortic valve replacement and the availability of efficient treatments, more patients are pursuing this procedure.
It is anticipated that 34 countries will have over 20% of their population over 65 by 2030 due to the world's aging population. China's population is aging rapidly; as a result of rising life expectancy and falling birth rates, China's population of individuals over 60 is expected to increase to 28% by 2040. In particular, the creation of an integrated system that meets the social and health requirements of older people while ensuring that everyone has access to health care regardless of location is made possible by this enormous demographic transition. A rapidly aging population necessitates the development of age-friendly towns and cities where the elderly can flourish and make valuable contributions to society. To enhance access to integrated care, China has been researching novel strategies. These elements would support the growth of the regional market.
The China market dominated the Asia Pacific Transcatheter Aortic Valve Replacement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $614.3 million by 2028. The Japan market is estimated to grow a CAGR of 7.8% during (2022-2028). Additionally, The India market would experience a CAGR of 9.1% during (2022-2028).
Based on Material, the market is segmented into Nitinol, Stainless Steel, Cobalt-Chromium and Others. Based on Implantation Procedure, the market is segmented into Transfemoral, Transapical and Transaortic. Based on Mechanism, the market is segmented into Balloon-expanding Valve and Self-expanding Valve. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, MicroPort Scientific Corporation, LivaNova PLC, TTK Healthcare Limited, Meril Life Science Private Limited, JenaValve Technology, Inc., and Bracco S.p.A.
Scope of the Study
By Material
- Nitinol
- Stainless Steel
- Cobalt-Chromium
- Others
By Implantation Procedure
- Transfemoral
- Transapical
- Transaortic
By Mechanism
- Balloon-expanding Valve
- Self-expanding Valve
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Transcatheter Aortic Valve Replacement Market, by Material
1.4.2 Asia Pacific Transcatheter Aortic Valve Replacement Market, by Implantation Procedure
1.4.3 Asia Pacific Transcatheter Aortic Valve Replacement Market, by Mechanism
1.4.4 Asia Pacific Transcatheter Aortic Valve Replacement Market, by End-use
1.4.5 Asia Pacific Transcatheter Aortic Valve Replacement Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Transcatheter Aortic Valve Replacement Market
Chapter 4. Asia Pacific Transcatheter Aortic Valve Replacement Market by Material
4.1 Asia Pacific Nitinol Market by Country
4.2 Asia Pacific Stainless Steel Market by Country
4.3 Asia Pacific Cobalt-Chromium Market by Country
4.4 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Transcatheter Aortic Valve Replacement Market by Implantation Procedure
5.1 Asia Pacific Transfemoral Market by Country
5.2 Asia Pacific Transapical Market by Country
5.3 Asia Pacific Transaortic Market by Country
Chapter 6. Asia Pacific Transcatheter Aortic Valve Replacement Market by Mechanism
6.1 Asia Pacific Balloon-expanding Valve Market by Country
6.2 Asia Pacific Self-expanding Valve Market by Country
Chapter 7. Asia Pacific Transcatheter Aortic Valve Replacement Market by End-use
7.1 Asia Pacific Hospitals Market by Country
7.2 Asia Pacific Ambulatory Surgical Centers Market by Country
7.3 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Transcatheter Aortic Valve Replacement Market by Country
8.1 China Transcatheter Aortic Valve Replacement Market
8.1.1 China Transcatheter Aortic Valve Replacement Market by Material
8.1.2 China Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.1.3 China Transcatheter Aortic Valve Replacement Market by Mechanism
8.1.4 China Transcatheter Aortic Valve Replacement Market by End-use
8.2 Japan Transcatheter Aortic Valve Replacement Market
8.2.1 Japan Transcatheter Aortic Valve Replacement Market by Material
8.2.2 Japan Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.2.3 Japan Transcatheter Aortic Valve Replacement Market by Mechanism
8.2.4 Japan Transcatheter Aortic Valve Replacement Market by End-use
8.3 India Transcatheter Aortic Valve Replacement Market
8.3.1 India Transcatheter Aortic Valve Replacement Market by Material
8.3.2 India Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.3.3 India Transcatheter Aortic Valve Replacement Market by Mechanism
8.3.4 India Transcatheter Aortic Valve Replacement Market by End-use
8.4 South Korea Transcatheter Aortic Valve Replacement Market
8.4.1 South Korea Transcatheter Aortic Valve Replacement Market by Material
8.4.2 South Korea Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.4.3 South Korea Transcatheter Aortic Valve Replacement Market by Mechanism
8.4.4 South Korea Transcatheter Aortic Valve Replacement Market by End-use
8.5 Singapore Transcatheter Aortic Valve Replacement Market
8.5.1 Singapore Transcatheter Aortic Valve Replacement Market by Material
8.5.2 Singapore Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.5.3 Singapore Transcatheter Aortic Valve Replacement Market by Mechanism
8.5.4 Singapore Transcatheter Aortic Valve Replacement Market by End-use
8.6 Malaysia Transcatheter Aortic Valve Replacement Market
8.6.1 Malaysia Transcatheter Aortic Valve Replacement Market by Material
8.6.2 Malaysia Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.6.3 Malaysia Transcatheter Aortic Valve Replacement Market by Mechanism
8.6.4 Malaysia Transcatheter Aortic Valve Replacement Market by End-use
8.7 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market
8.7.1 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market by Material
8.7.2 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.7.3 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market by Mechanism
8.7.4 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market by End-use
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Approvals and Trials:
9.2.6 SWOT Analysis
9.3 Boston Scientific Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.5.2 Acquisition and Mergers:
9.3.5.3 Approvals and Trials:
9.4 Edwards Lifesciences Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 MicroPort Scientific Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 LivaNova PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 TTK Healthcare Limited
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Meril Life Sciences Private Limited
9.8.1 Company Overview
9.9 JenaValve Technology, Inc.
9.9.1 Company Overview
9.10. Bracco S.p.A.
9.10.1 Company Overview
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- MicroPort Scientific Corporation
- LivaNova PLC
- TTK Healthcare Limited
- Meril Life Science Private Limited
- JenaValve Technology, Inc.
- Bracco S.p.A
Methodology
LOADING...
